N(1)-anthracen-9-ylmethyl, N(1)-2-(anthracen-9-yl)ethyl, N(1)-3-(anthracen-9-yl)propyl, and pyren-1-ylmethyl. The polyamine architecture was also altered and ranged from diamine to triamine and tetraamine systems. Biological activities in L1210 (murine leukemia), Chinese hamster ovary (CHO), and CHO's polyamine transport-deficient mutant (CHO-MG) cell lines were investigated via IC(50) cytotoxicity determinations
合成了几种含有各种芳环系统的N(1)-芳基烷基
多胺作为它们各自的HCl盐。评估的N(1)取代基大小从N(1)-苄基,N(1)-
萘-1-基甲基,N(1)-2-(
萘-1-基)乙基,N(1) -3-(
萘-1-基)丙基,N(1)-
蒽-9-基甲基,N(1)-2-(
蒽-9-基)乙基,N(1)-3-(
蒽-9 -基)丙基和pyr-1-基甲基。
多胺的结构也被改变,范围从二胺到三胺和四胺体系。通过IC(50)细胞毒性测定研究了L1210(鼠白血病),中国仓鼠卵巢(CHO)和CHO的
多胺转运缺陷型突变体(CHO-MG)
细胞系的
生物学活性。L1210细胞中
亚精胺摄取的K(i)值也已确定。N(1)-芳基烷基取代基的大小以及所用的
多胺序列直接影响到观察到的细胞毒性谱。如CHO / CHO-MG细胞毒性筛选所示,比
乙烯长的N(1)-系链显示出对
多胺转运蛋白(PAT)的选择性显着丧失。总之,对于N(1)取代基的大小有明确